Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shenzhen Edge Medical CoFRA:R5Z -0.96%20 Forward PE Ratio is 250.63 as of Aug. 14, 2026. GuruFocus rates FRA:R5Z with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 391 Medical Devices & Instruments companies, Shenzhen Edge Medical Co ranks worse than 96.42% on this metric.
Shenzhen Edge Medical Co (FRA:R5Z) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Shenzhen Edge Medical Co Forward PE Ratio Related Terms
Shenzhen Edge Medical Co Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Edge Medical Co Forward PE Ratio Chart
Shenzhen Edge Medical Co Annual Data
Trend
Forward PE Ratio
Shenzhen Edge Medical Co Semi-Annual Data
Forward PE Ratio
FRA:R5Z vs ABT, SYK, MDT: Forward PE Ratio Comparison
For the Medical Devices subindustry, Shenzhen Edge Medical Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Edge Medical Co Forward PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Edge Medical Co's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Shenzhen Edge Medical Co's Forward PE Ratio falls into.
Shenzhen Edge Medical Co Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Shenzhen Edge Medical Co (FRA:R5Z) has a Forward PE Ratio of 250.63 as of Aug. 14, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Shenzhen Edge Medical Co and its competitors. According to the industry distribution chart, Shenzhen Edge Medical Co ranks #377 out of 391 companies in the Medical Devices & Instruments industry, placing it in the top 96.4%.
Is Shenzhen Edge Medical Co's Forward PE Ratio too high?
Shenzhen Edge Medical Co's current Forward PE Ratio is 250.63. The Medical Devices & Instruments industry median Forward PE Ratio is 20.23. Shenzhen Edge Medical Co's value of 250.63 is 1138.9% above this industry median. Based on the distribution chart, Shenzhen Edge Medical Co ranks #377 out of 391 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shenzhen Edge Medical Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Edge Medical Co's Forward PE Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen Edge Medical Co ranks #377 out of 391 companies for Forward PE Ratio. This places Shenzhen Edge Medical Co in the lower half of its industry. The industry median Forward PE Ratio is 20.23. Shenzhen Edge Medical Co's value of 250.63 is 1138.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 20.23, based on 391 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Edge Medical Co's current Forward PE Ratio of 250.63 is 1138.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Shenzhen Edge Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 20.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Edge Medical Co's current Forward PE Ratio is 250.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Edge Medical Co stock overvalued right now?
Shenzhen Edge Medical Co (FRA:R5Z) has a current Forward PE Ratio of 250.63. The current Forward PE Ratio is 250.63 and 1138.9% above the Medical Devices & Instruments industry median of 20.23. Shenzhen Edge Medical Co's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Shenzhen Edge Medical Co (FRA:R5Z), the current Forward PE Ratio is 250.63 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shenzhen Edge Medical Co Ltd is principally engaged in the designing, research and development, manufacturing and sale of surgical robots. It has a pipeline of three products and product candidates covering various models at different development stages to capture the market potential in surgical robots, including Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot for MIS, as well as Edge Bronchoscope Robot for non-invasive surgery. The company derives revenue principally from the sales of surgical robot systems, instruments and accessories, and provision of services. Geographically, the maximum revenue is generated from the Chinese mainland, followed by Asia (other than Chinese Mainland), Europe, and Others.
20GF Score
Get the complete analysis for FRA:R5Z
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:R5Z has been successfully added to your 
